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Background: In young males, an acute myocardial infarction is an uncommon event. Thromboembolism caused 
by nephrotic syndrome (NS) is one of the pathophysiologies of their infarctions.
Objective: This study aimed to elaborate the case of acute St-Elevation Myocardial Infarction (Stemi) in young 
male with nephrotic syndrome 
Case Presentation: A-24-y.o male patient, came with prolonged typical chest pain 72 hours before admission. The 
electrocardiogram (ECG) from the chest leads indicated ST-Elevation. Cardiac troponin was significantly 
elevated. For the last two weeks, he had been experiencing nephrotic syndrome symptoms including anasarca 
edema. It was supported by laboratory data which showed proteinuria, hyperlipidemia, and hypoalbuminemia. 
Coronary angiography showed complete acute occlusion of the left proximal anterior descending artery segment. 
Coronary angiography indicated complete acute occlusion of the left proximal anterior descending artery 
segment. The hypercoagulable condition in this patient was seen to be influenced by the increased fibrinogen 
levels, implying a correlation between coronary thrombosis and nephrotic syndrome.
Conclusion: Nephrotic syndrome should be considered as a contributing factor in any patient presenting with 





 Approximately only 4% of acute myocardial infarction in 
patients before the age of 40 years old occur in young males.1 In older 
patients, the main underlying disease is typically atherosclerotic plaque 
rupture. But in young patients, infarcts may have a variety of 
pathophysiology.2 Nephrotic syndrome (NS) caused Thromboembolism 
is one of the pathophysiologies of their infarctions. Since NS is a 
relatively uncommon cause of acute coronary syndrome (ACS), the 
prevalence, pathogenesis, and treatment of these patients are still 
unclear.
 This case aimed to describe the occurrence of acute myocar-
dial infarction in a young adult, which was most likely caused by 
arterial thrombosis caused by the hypercoagulable state in nephrotic 
syndrome. In young people with chest pain, acute myocardial infarction 
should be considered, even though it is an uncommon occurrence. A 
thorough clinical history may help to determine the cause and guide 
treatment, but diagnostic coronary angiography is also required. Recur-
rent cardiac events should be minimized by careful risk factor manage-
ment and treatment of the underlying cause.3,4,5 
2. Case Presentation
 A-24-years-old male patient, presented at our hospital ER 
with progressive typical chest pain since 72 hours before admission 
along with cold sweating, vomiting, and shortness of breath. He also 
complained of anasarca edema for the last two weeks.  As his chest pain 
was not relieved by rest, he was brought to the nearest private hospital. 
There, the ECG showed anterior extensive STEMI (figure 1) and he got 
some medications, including loading Aspilet 320 mg, Clopidogrel 300 
mg, ISDN 3x5 mg, Furosemide 40 mg intravenously, and Fondaparinux 
1x2,5mg subcutaneously. On the second day of care at the first hospital, 
the pain worsened and they decided to refer him to our hospital for 
further management. There was a delay in referring him to a hospital 
capable of performing PCI due to financial issues. He had been an active 
smoker for 10 years, smoking 1 pack per day. He was also an alcoholic. 
There was no history of ischemic heart disease, Diabetes Mellitus, 
hypertension, or sudden cardiac death in his family.
 At the time of admission, physical examination revealed that 
his blood pressure was 145/101 mmHg, heart rate 118 bpm, respiratory 
rate 22 per minute, oxygen saturation 95% on room air. He had
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palpebra, scrotal, and bilateral ankle oedema and ascites. Laboratory 
finding showed elevated cardiac troponin I (55.8 ug/L), CKMB (213 
U/L), elevated fibrinogen (645,8 mg/dL); normal renal function with 
serum creatinine 1.26 mg/dL, ureum 38.9 mg/dL; severe Hypoalbu-
minemia (1.48 g/dL); low-density lipoprotein cholesterol, 431 mg/dL;
and triglyceride, 299 mg/dL. Twenty-four hours urine analysis showed 
albuminuria (62.2 mg/dL). Urinalysis showed protein 3+; blood 3+. 
Complete blood count was normal; SGOT 221 U/L; SGPT 82 U/L; 
NT-Pro BNP 6122 pg/mL. ANA/anti-dsDNA were negative. The electro-
cardiogram showed an anterior extensive MI (Figure 2). The coronary 
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Figure 1. ECG at the local hospital showed ST-elevation in chest leads
Figure 2. Electrocardiogram on admission, shows Sinus Rhythm with HR 125 bpm, frontal axis normal, horizontal axis clockwise rotation, normal p 
wave, PR duration 120ms, QRS duration 90ms, ST-elevation I, AVL, V1 - V6, ST depression III, QS I AVL, V1-V4
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angiography revealed complete thrombotic occlusion of the mid-left 
anterior descending artery (LAD), while the left circumflex arteries and 
right coronary artery were normal (Figure. 3), The occluded artery was 
recanalized by a guidewire crossing of the thrombus, followed by 
thrombosuction. which resulted in a large amount of white thrombus 
and implantation of a drug-eluting stent at mid – distal LAD. Echocardi-
ography showed that LV ejection fraction was reduced to 42%. There 
was akinesia in the anteroseptal, apicoseptal, and apicoanterior area, as 
well as hypokinesia in the mid anterior area.
 Six days after admission, he was discharged on daily aspirin 
(80 mg), ticagrelor (90 mg bid), atorvastatin (20 mg), Ramipril (10 
mg), Bisoprolol (2,5 mg), and methylprednisolone (3x16 mg). He 
followed up with the nephrologist for immunosuppressive therapy. He 
remained stable and asymptomatic at the three-month follow-up. The 
LDL-C and triglyceride were well below 120.74 mg/dL and 141.76 
mg/dL, and the albuminuria was 2.5 g/24 hours. 
3. Discussion
 Acute myocardial infarction (AMI), which is uncommon in 
young adults, is categorized into two forms. Clear coronaries are a 
condition caused by coronary artery embolism, thrombosis, spasms, or 
a mix of these factors. Hypercoagulable states such as antiphospholipid 
syndrome, nephrotic syndrome, and others may cause coronary throm-
bosis. Including In this patient, the result of coronary angiography was 
one vessel disease with thrombotic occlusion with high burden throm-
bus in LAD, while the other coronary arteries were normal. Another 
condition is abnormal coronary, which involves significantly accelerat-
ed atherosclerosis, aneurysm, Spontaneous dissection, and coronary 
artery anomalous origin.6 The pathophysiology between these two 
groups is significantly overlapping.
 The involvement of anasarca edema, proteinuria, hypoalbu-
minemia, and hyperlipidemia in this patient indicated nephrotic 
syndrome. In addition, based on the symptom of typical chest pain, 
electrocardiography, and laboratory findings on admission, the patient 
had an acute myocardial infarction. We suggest that his acute myocar-
dial infarction probably might be caused by arterial thrombosis, which 
might have been due to the hypercoagulable state caused by the 
nephrotic syndrome. However, he had tobacco smoking as an addition-
al risk factor. Myocardial infarction pathophysiology in nephrotic
patients is still uncertain. According to Fahal et al, thrombosis is most 
common in the first few months after a diagnosis, but it can occur at any 
time during the course of NS.7 Several risk factors for thrombotic 
complications in nephrotic patients have been identified. Plasma 
hypercoagulability has long been known to be responsible for the 
nephrotic syndrome's tendency for thrombotic episodes. The alteration 
of blood level and function of antithrombotic and prothrombotic factors 
could cause hypercoagulability.7,8,9 Urinary loss decreases the levels of 
factors IX, XI, XII, and antithrombin III. Low antithrombin III levels 
were seem insufficient for these procoagulant factors to be inactivated 
which resulted in thrombosis.3,10,11,12 Factor XII, protein C, and protein S 
deficiencies were all related to an increase in thromboembolic events in 
nephrotic patients. Similarly, hypoalbuminemia triggered increased 
synthesis in the liver which resulted in higher levels of fibrinogen, 
factors II, V, VII, VIII, and X. Higher fibrinogen levels have been shown 
to change plasma viscosity.3,10,11,12 Hypoalbuminemia in NS causes 
intravascular dehydration. Platelet dysfunction was a common and 
significant abnormality in nephrotic syndrome.13,14 It is considered that 
the high incidence of thromboembolic consequences is due to an 
increase in platelet aggregation. Nephrotic hyperlipidemia, which was 
found in our patient, might be another factor in MI.15 Diuretics which 
intended to decrease the edema caused by NS might induce hemocon-
centration and increased the risk of thrombosis.13 Similarly, steroids 
used to treat NS, as in this patient, could cause alteration of the blood 
level of coagulation factors, aggravating hypercoagulability thus 
causing thrombosis.7,8 Additional risk factors in this patient include 
being an active smoker and an alcoholic.
 Acute MI management in this context, is comparable with MI 
management in general. Primary percutaneous coronary transluminal 
angioplasties were utilized with or without coronary artery stenting in 
some cases.2,4,5 Thrombolysis has been reported to be successful in 
comparable cases.3,4,5 Prophylactic anticoagulation is only recommend-
ed in idiopathic membranous nephropathy, according to the 2012 
Kidney Disease: Improving Global Outcomes (KDIGO) guidelines; 
however, available evidence indicates that anticoagulation should be 
considered in all patients with NS.16 Prophylactic anticoagulation role in 
patients with NS who do not have thrombotic complications is still 
debated. Considering that platelets are the primary cause of arterial 
thrombi in NS, the use of antiplatelet agents such as aspirin seems 
rational, and some practitioners prescribe long-term low-dose aspirin in 
patients with chronic NS. Other general measures, such as hypertension
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Figure 3. (A) Coronary angiography showed complete thrombotic occlusion of the proximal left anterior descending branch (LAD) (B) Coronary 
flow following aspiration of thrombus and insertion of a stent in LAD.
(A) (B)
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management, hyperlipidemia treatment, smoking cessation, and 
proteinuria reduction with angiotensin-converting enzyme inhibitors 
and/or angiotensin receptor blockers, are also beneficial.2,7,8
4. Conclusion
 In the absence of atherosclerotic disease, young patients may 
suffer acute coronary events. In any patient diagnosed with ischemic 
heart disease and renal diseases, nephrotic syndrome should be taken 
as a risk factor.
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